← Leaderboards
Teodor T Postolache
Baltimore Va Medical Center
$2,330,190
Attributed
$2,330,190
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $795.8K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,330,190 · 10
VA$0 · 2
By mechanism
R01$1,049,127 · 1
R34$607,500 · 1
R21$362,693 · 1
M01$189,046 · 6
K18$121,824 · 1
I01$0 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Reporting”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$564,567,727
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Bambra Strokes · Ppd Development Lp$461,655,950
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ReportingMediatingSuicideResearch PersonnelPharmaceutical PreparationsFutureParticipantLinkBloodBaseCytokineInflammationDesignSeasonal Affective DisorderMental DepressionMoodsDiagnosisRecording Of Previous EventsSuicidal RiskResponseSuicide AttemptMediationSuicide PreventionKynurenine
Grant awards (23)
Suicide risk modification by statin prescriptions in US Veterans with common inflammation-mediated clinical conditions- a controlled, quasi-randomized epidemiological approach$0
I01 · FY2025 · VA · contact PI
Suicide risk modification by statin prescriptions in US Veterans with common inflammation-mediated clinical conditions- a controlled, quasi-randomized epidemiological approach$0
I01 · FY2024 · VA · contact PI
Suicide risk modification by statin prescriptions in US Veterans with common inflammation-mediated clinical conditions- a controlled, quasi-randomized epidemiological approach$0
I01 · FY2023 · VA · contact PI
Toxoplasma gondi, the kynurenine pathway, and suicidal behavior in veterans$0
I01 · FY2020 · VA · contact PI
Toxoplasma gondi, the kynurenine pathway, and suicidal behavior in veterans$0
I01 · FY2019 · VA · contact PI
Toxoplasma gondi, the kynurenine pathway, and suicidal behavior in veterans$0
I01 · FY2018 · VA · contact PI
Toxoplasma gondi, the kynurenine pathway, and suicidal behavior in veterans$0
I01 · FY2017 · VA · contact PI
Toxoplasma gondi, the kynurenine pathway, and suicidal behavior in veterans$0
I01 · FY2016 · VA · contact PI
Seasonality of Mood: A Genome-Wide Association Study in the Old Order Amish$121,824
K18 · FY2010 · MH · contact PI
Seasonality of Suicide and Airborne Allergens$286,771
R01 · FY2009 · MH · contact PI
Light Treatment for Winter-SAD: Prediction of Response by Immediate Improvement$202,500
R34 · FY2009 · MH · contact PI
LIGHT TREATMENT FOR WINTER SEASONAL AFFECTIVE DISORDER$69,148
M01 · FY2009 · RR · contact PI
SEASONALITY OF DEPRESSION AND AIRBORNE ALLERGENS$24,508
M01 · FY2009 · RR · contact PI
SEASONALITY OF SUICIDE AND AIRBORNE ALLERGENS$336,541
R01 · FY2008 · MH · contact PI
Light Treatment for Winter-SAD: Prediction of Response by Immediate Improvement$202,500
R34 · FY2008 · MH · contact PI
SEASONALITY OF DEPRESSION AND AIRBORNE ALLERGENS$68,478
M01 · FY2008 · RR · contact PI
INFLAMMATION AS A POSSIBLE FACTOR IN THE DEVELOPMENT OF POSTPARTUM DEPRESSION$15,609
M01 · FY2008 · RR · contact PI
LIGHT TREATMENT FOR SAD$6,042
M01 · FY2008 · RR · contact PI
SEASONALITY OF SUICIDE AND AIRBORNE ALLERGENS$425,815
R01 · FY2007 · MH · contact PI
Light Treatment for Winter-SAD: Prediction of Response by Immediate Improvement$202,500
R34 · FY2007 · MH · contact PI
Mood Worsening in Spring in Women with Depression and Tree-Pollen Allergy$162,218
R21 · FY2007 · MH · contact PI
INFLAMMATION FACTORS IN POSTPARTUM DEPRESSION$5,261
M01 · FY2007 · RR · contact PI
Mood Worsening in Spring in Patients with Recurrent Depression and Tree-Pollen Al$200,475
R21 · FY2006 · MH · contact PI